Post-Acute Brain Injury Urinary Signature: A New Resource for Molecular Diagnostics

Abstract

Heterogeneity within brain injury presents a challenge to the development of informative molecular diagnostics. Recent studies show progress, particularly in cerebrospinal fluid, with biomarker assays targeting one or a few structural proteins. Protein-based assays in peripheral fluids, however, have been more challenging to develop, in part because of restricted and intermittent barrier access. Further, a greater number of molecular variables may be required to inform on patient status given the multi-factorial nature of brain injury. Presented is an alternative approach profiling peripheral fluid for a class of small metabolic by-products rendered by ongoing brain pathobiology. Urine specimens were collected for head trauma subjects upon admission to acute brain injury rehabilitation and non-traumatized matched controls. An innovative data-independent mass spectrometry approach was employed for reproducible molecular quantification across osmolarity-normalized samples. The postacute human traumatic brain injury urinary signature encompassed 2476 discriminant variables reproducibly measured in specimens for subject classification. Multiple subprofiles were then discerned in correlation with injury severity per the Glasgow Comma Scale and behavioral and neurocognitive function per the Patient Competency Rating Scale and Frontal Systems Behavioral Scale. Identified peptide constituents were enriched for outgrowth and guidance, extracellular matrix, and post-synaptic density proteins, which were reflective of ongoing post-acute neuroplastic processes demonstrating pathobiological relevance. Taken together, these findings support further development of diagnostics based on brain injury urinary signatures using either combinatorial quantitative models or pattern-recognition methods. Particularly, these findings espouse assay development to address unmet diagnostic and theragnostic needs in brain injury rehabilitative medicine.

MMP-9-Dependent Serum-Borne Bioactivity Caused by Multiwalled Carbon Nanotube Exposure Induces Vascular Dysfunction via the CD36 Scavenger Receptor

“…Separation was performed with a 150 mm × 75 μm HSS T3 reversed-phase capillary column at 55 °C online with a nanoelectrospray equipped Synapt G2 HDMS tandem mass spectrometer (Waters). Separation and data-independent mass spectrometric analysis with ion mobility was performed as described previously (Fuller et al , 2012; Ottens et al , 2014) with the modifications that gradient elution was performed from 2% to 42% acetonitrile in water (formic-acid modified) and spectra were collected between 200 and 1800 m/z, with a collisionenergy ramp from 32 to 52 eV. All spectra were post-processed employing PLGS ion processing software (Waters).…”

Mind the gaps—advancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussions

“…[153][154][155][156] Data from animal models suggest that lipid and metabolite changes accompany both acute and chronic postconcussion periods, and could be useful for predicting recovery trajectory, 157,158 but these findings have yet to be validated in humans. Expanding the biomarker search beyond blood and CSF to saliva and urine 159 might improve the ability to obtain measurements rapidly and noninvasively, particularly from children. Sampling of CSF from children, particularly when rapid assessment is desirable, is largely impractical.…”

Biomarkers of Traumatic Brain Injury: Temporal Changes in Body Fluids

“…Urine is sampled noninvasively and can be an appropriate sample source in decentralized field assay conditions. The route of biomarkers from the brain to urine is indirect and contains potential barriers and dilutive interfaces, yet markers of brain injury have been found in urine (Rodríguez-Rodríguez et al, 2012; Ottens et al, 2014; Oliver et al, 2015). …”